Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.6 has been added to the record history, replacing the previous v3.6.5 entry. This reflects the latest update to the ClinicalTrials.gov record for NCT01909453.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new Revision: v3.6.5 entry was added to the version history, and the previous Revision: v3.6.4 entry was removed. This updates the history to reflect the latest site revision.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry v3.6.4 appears in the history, replacing the previous v3.6.3, indicating a minor update to the page’s version.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision tag updated to v3.6.3 on the Study Record History page, replacing the previous v3.6.2. This indicates a minor page revision in the site's revision history interface.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.6.2 appears in the record history, replacing v3.6.0. This marks a minor platform/format update to the page's history display with no changes to the study data or trial details.SummaryDifference0.1%

- Check78 days agoChange DetectedThe history now shows recruitment is closed (no longer looking for participants). The revision note was updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.